News

CURRENTLY RECRUITING FOR ECZEMA CLINICAL TRIALS

We will beginning our next cohort of patients on the 28th of May. Ensure you get in touch ASAP as spots are limited, and you will require a pre-screening appointment prior to the 28th.

12186637_515580835287139_8401734979629843626_o_opt

New Psoriasis Trial at St George Dermatology

Associate Professor Stephen Shumack is very excited to announce a new psoriasis trial has recently opened at St George Dermatology. The trial is for people with moderate to severe chronic plaque psoriasis. It is looking at a new medication that is targeted to the specific part of the immune system that is over active in psoriasis patients.

It has had some very promising results in previous studies. The trial goes for one year, over which time patients have 5 doses of medication (week 0, week 4 and then every 12 weeks, given via an injection). Associate Professor Stephen Shumack is very pleased to be able to make this product available to suitable patients in the St George and Sutherland Shire area. There has already been great interest and it is expected numbers will fill quickly. Should you be interested in participating in this study please call Sharyn on 9587 4277 between 10am and 3pm Monday to Friday.  

Australasian College of Dermatologists 50th Annual Scientific Meeting

The Australasian College of Dermatologists 50th Annual Scientific Meeting will be held in Sydney 6-9th May 2017.  The program also includes meetings of the Australian Dermatology Nurses’ Association and the Australasian Society of Cosmetic Dermatologists.

 

We are now treating with Kleresca®

Kleresca® is a breakthrough BioPhotonic treatment that significantly and comfortably improves acne, with high safety. It is offered exclusively in professional clinics.

Kleresca® harnesses the power of BioPhotonics to safely treat your acne and stimulate the tissue’s own repair systems. The treatment uses a high intensity in-clinic lamp together with a photoconverter gel to kill bacteria in the skin and initiate healing.

Kleresca® is administered twice a week for six weeks. The treatment offers you a comfortable experience. A nurse or practitioner will apply a topical orange gel that is illuminated under a multi-wavelength LED light for nine minutes. That’s all – then you can get back to your day!

For more information: http://www.kleresca.com.au/en-au